CES2 and neoplasm: Since the enhancement of TurboID biotinylation efficiency by BME in living cells depends on the expression of CES1 and CES2, we compared the expression of these genes in the common tumor cell lines (HeLa, HEK293T, and U937) and in normal endothelial, fibroblast, epithelial, and epidermal cells.